Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Canada: POC (point-of-care) devices for OAT (oral anticoagulation therapy) improve health, can reduce costs and need investment

This article was originally published in Clinica

Executive Summary

Canada has found that portable point-of-care (POC) devices to monitor long-term oral anticoagulation therapy (OAT) "compare with standard laboratory testing in clinical and cost effectiveness", but additional resources are required. This is the conclusion of a report published this month by the Canadian Agency for Drugs and Technologies in Health (CADTH).

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT047579

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel